Logo

OncoCyte

People in the News: Collins to Depart NIH; Appointments at Oncocyte, Roswell Biotech; and More

Oncocyte Launches Prospective Registry to Drive DetermaRx Adoption, Improve Coverage
Premium

Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment.

Oncocyte Updates Plans for Chronix Transplant Tech; Will Develop and Market Kits in Europe
Premium

The move opens the first non-oncology application for Oncocyte, which acquired the relevant cell-free DNA technology in its merger with Chronix this April.

Oncocyte Sees $2M in Q2 Revenues, Beating Wall Street Estimate

The company said a technology transfer agreement with Burning Rock Biotech drove the increase, though clinical test sales also rose year over year.

EchelonDx, Oncocyte to Develop Software Supporting Commercial Diagnostics Expansion

The two firms are developing an analytical software solution to help Oncocyte scale its commercial oncology test business to a global scale.

Jun 14, 2021

Oncocyte Inks At-Market Agreement to Sell Up to $50M in Stock

Jun 3, 2021

Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer

May 17, 2021

Oncocyte Posts $1.1M in Q1 Revenues, Beating Wall Street Expectations

Apr 12, 2021

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Mar 18, 2021

Oncocyte Details New Expansions Plans With Growing Portfolio of Acquired Tests
Premium

Mar 16, 2021

Oncocyte Posts $503K in Q4 Revenues, Misses Wall Street Expectations

Mar 12, 2021

People in the News: New Appointments at Oncocyte, Ontera, Agilent, More

Feb 25, 2021

Oncocyte Closes Second and Final Investment in Razor Genomics Acquisition

Feb 5, 2021

Oncocyte to Raise $35M in Public Stock Offering

Feb 2, 2021

Oncocyte to Acquire Chronix Biomedical

Jan 20, 2021

Oncocyte to Raise $25M in Stock Sale to Institutional Investors

Dec 16, 2020

Piper Sandler Raises Rating on Oncocyte to Overweight

Dec 15, 2020

Burning Rock Biotech Licenses Oncocyte Lung Cancer Assay

Nov 30, 2020

BTIG Initiates Coverage of Oncocyte With Buy Rating

Nov 12, 2020

OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises

Oct 21, 2020

Oncocyte DetermaRx Predicts Early Lung Cancer Outcomes Regardless of EGFR Status
Premium

Oct 8, 2020

Oncocyte, Fondazione Michelangelo to Evaluate DetermaIO Test for Immunotherapy Response Prediction

Oct 2, 2020

In Brief This Week: Illumina, BGI, Thermo Fisher, Genetron, Yourgene, Caris Life Sciences, More

Oct 1, 2020

Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology

Sep 3, 2020

Oncocyte, Guardian Research Network Partner to Improve Precision Medicine Clinical Trials

Breaking News
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more